AVTXVSMRNA• 3 Months (Normalized)
AVTX vs MRNA (Avalo Therapeutics Inc. vs Moderna Inc.)
Showing Closing Date Range from Jun, 16 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AVTX Performance $16.18
+12.91%
Avalo Therapeutics Inc.
Normalized Baseline0.00%
MRNA Performance $146.69
+164.78%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-151.87%
MRNA outperforming by 151.87%
AVTXMRNA
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AVTX MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | AVTX Price | AVTX Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $16.18 | +12.91% | $146.69 | +164.78% | -151.87% |
| Sep 11, 2026 | $16.12 | +12.49% | $143.97 | +159.87% | -147.38% |
| Sep 10, 2026 | $17.18 | +19.89% | $136.62 | +146.61% | -126.72% |
| Sep 09, 2026 | $18.21 | +27.08% | $135.61 | +144.78% | -117.70% |
| Sep 08, 2026 | $19.71 | +37.54% | $140.33 | +153.30% | -115.76% |
| Sep 04, 2026 | $19.23 | +34.19% | $145.55 | +162.73% | -128.54% |
| Sep 03, 2026 | $19.00 | +32.59% | $148.87 | +168.72% | -136.13% |
| Sep 02, 2026 | $19.34 | +34.96% | $150.81 | +172.22% | -137.26% |
| Sep 01, 2026 | $18.95 | +32.24% | $154.27 | +178.47% | -146.23% |
| Aug 31, 2026 | $19.34 | +34.96% | $140.34 | +153.32% | -118.36% |
| Aug 28, 2026 | $19.59 | +36.71% | $137.99 | +149.08% | -112.37% |
| Aug 27, 2026 | $20.05 | +39.92% | $142.77 | +157.71% | -117.79% |
| Aug 26, 2026 | $20.55 | +43.41% | $149.66 | +170.14% | -126.73% |
| Aug 25, 2026 | $19.74 | +37.75% | $158.83 | +186.70% | -148.95% |
| Aug 24, 2026 | $19.27 | +34.47% | $138.89 | +150.70% | -116.23% |
Page 1 of 5